Biotechnology Amgen Stock Adds Good Weight After CEO’s Update On Experimental Drug Rivaling Ozempic, Nixing Oral Weight-Loss Candidate – Amgen (NASDAQ:AMGN) Read more
Biotechnology Amgen Outlook Is Bright, Analyst Predict Obesity-Focused Drug Potential Will Drive Shareholder Value – Amgen (NASDAQ:AMGN) Read more
Biotechnology Biogen/Eisai’s Popular Alzheimer’s Drug Leqembi Is Seeing Slow Adoption – Here’s Why – Biogen (NASDAQ:BIIB) Read more
Biotechnology Why Is Liver-Disease Drug Developer Hepion Pharmaceuticals Stock Trading Lower On Monday? – Hepion Pharmaceuticals (NASDAQ:HEPA) Read more
Biotechnology US Supreme Court Declines To Hear Vanda Pharmaceuticals’ Case Regarding Invalidation Of Patents For Its Sleep Disorder Drug, Hetlioz – Vanda Pharma (NASDAQ:VNDA) Read more
Biotechnology Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025 – Eli Lilly and Co (NYSE:LLY) Read more
Biotechnology Amgen/AstraZeneca’s Asthma Drug Tezspire Vs. Sanofi/Regeneron’s Blockbuster Dupixent – Analyst Gives His Pick – AstraZeneca (NASDAQ:AZN), Amgen (NASDAQ:AMGN) Read more
Biotechnology Novartis Multiple Sclerosis Drug Kesimpta Shows Substantial Benefit Of Up To 6 Years – Novartis (NYSE:NVS) Read more
Biotechnology IGC Pharma Says Cannabinoid-Based Drug Candidate Provides Fast Relief With Fewer Side Effects For Alzheimer’s-Associated Agitation – IGC Pharma (AMEX:IGC) Read more